Follow on Google News News By Tag * Lundbeck * Prescription * Pharmaceutical * 2003-15 * Pharmavitae * 2003-09 * Molecule * Therapy * Revenuecost * Cipralex * More Tags... Industry News News By Location Country(s) Industry News
Follow on Google News | "H. Lundbeck A/S: PharmaVitae Profile" is now available at Fast Market ResearchNew Pharmaceuticals research report from Datamonitor is now available from Fast Market Research
This analysis examines the historical and forecast performance for Lundbeck in the prescription pharmaceutical sector. The profile encompasses global company strategy, portfolio and pipeline analysis and assessment of financial performance, with 1-6 year sales forecasts for key drugs. Features and benefits * Gain insight into Lundbeck's strategic outlook across the next 6 years* Analyze company sales forecasts by product, therapy area, lifecycle stage, geography, molecule type and source Highlights Strategic insight into the prospects for Lundbeck over the next six years. Picking out key strengths, weaknesses, opportunities and threats and evaluating the company's prescription pharmaceuticals outlook using a variety of cuts of the historical and forecast sales. Your key questions answered ------------------------------------------------------------ Full Report Details at - http://www.fastmr.com/ ------------------------------------------------------------ * Benchmark Lundbeck's performance against key rivals in the prescription pharmaceutical sector* Assess the company's position versus key rivals in its core CNS focus market* Analyze how Lundbeck has increasingly used externalization strategies to both boost R&D productivity and enhance its geographic footprint Report Table of Contents: TABLE OF CONTENTS ABOUT DATAMONITOR HEALTHCARE About the PharmaVitae team Chapter 1 About this profile PharmaVitae Explorer database Chapter structure Data sourcing Chapter 2 Executive summary Key findings Prescription pharmaceutical sales and growth rate performance, 2003-15 Financial performance, 2003-15 Lundbeck: PharmaVitae forecasts at a glance Strategic insight SWOT analysis Chapter 3 Quarterly update Latest quarterly sales Latest comment Latest prescription pharma product news Latest corporate news Chapter 4 Company introduction Key findings Background Key corporate developments M&A history Current corporate structure Chapter 5 Company sales Key findings Prescription pharmaceutical sales and growth rate analysis, 2003-15 Product analysis Therapy area analysis Geographic analysis Launch/core/ Molecule type analysis Externalization analysis Chapter 6 Company financials Key findings Reconciliation between PharmaVitae- Operating costs and profit analysis Chapter 7 Key products and competitors Overview Cipralex (including Lexapro royalties) Ebixa Chapter 8 Appendix References Abbreviations Exchange rates About Datamonitor Datamonitor consulting Disclaimer TABLE OF TABLES Table 1: Lundbeck - PharmaVitae forecasts at a glance Table 2: Lundbeck quarterly sales ($m), Q309-Q310 Table 3: Lundbeck product portfolio overview ($m), 2003-09 Table 4: Lundbeck product portfolio overview ($m), 2009-15 Table 5: Lundbeck prescription pharmaceutical sales by therapy area ($m), 2009-15 Table 6: Lundbeck prescription pharmaceutical sales by geographic region ($m), 2009-15 Table 7: Lundbeck launch portfolio overview ($m), 2009-15 Table 8: Lundbeck core portfolio overview ($m), 2009-15 Table 9: Lundbeck expiry portfolio overview ($m), 2009-15 Table 10: Lundbeck prescription pharmaceutical sales by molecule type ($m), 2009-15 Table 11: Lundbeck prescription pharmaceutical sales by source ($m), 2009-15 Table 12: Total Lundbeck sales by business unit ($m), 2003-09 Table 13: Lundbeck operating revenue/cost analysis ($m), 2003-09 Table 14: Lundbeck operating cost ratio analysis (% of total revenues), 2003-09 Table 15: Lundbeck operating cost ratio analysis (% of total revenues), 2009-15 Table 16: Lundbeck operating revenue/cost analysis ($m), 2009-15 Table 17: Key products overview Table 18: Cipralex: overview Table 19: Cipralex: sales forecast ($m), 2008-14 Table 20: Ebixa: overview Table 21: Ebixa: sales forecast ($m), 2009-15 Table 22: Exchange rates, 2010 TABLE OF FIGURES Figure 1: The PharmaVitae Explorer Figure 2: Lundbeck prescription pharmaceutical performance, sales ($m) and growth rate (%), 2003-15 Figure 3: Lundbeck's financial performance ($m), 2003-15 Figure 4: Share of CNS market in 5EU and 'rest of world' by company (%), 2009-15 Figure 5: Lundbeck SWOT analysis Figure 6: Lundbeck prescription pharmaceutical performance, sales ($m) and growth rate (%), 2003-15 Figure 7: Key product sales ($m), 2003-15 Figure 8: Lundbeck key sales growth drivers and resistors ($m), 2003-09 Figure 9: Lundbeck key sales growth drivers and resistors ($m), 2009-15 Figure 10: Lundbeck prescription pharmaceutical sales by therapy area ($m), 2003-15 Figure 11: Lundbeck prescription pharmaceutical sales by geographic region ($m), 2003-15 Figure 12: Lundbeck launch/core/ Figure 13: Lundbeck prescription pharmaceutical sales by molecule type ($m), 2003-15 Figure 14: Lundbeck prescription pharmaceutical sales by source ($m), 2003-15 Figure 15: Lundbeck operating revenue/cost analysis ($m), 2003-15 About Datamonitor The Datamonitor Group is a world-leading provider of premium global business information, delivering independent data, analysis and opinion across the Automotive, Consumer Markets, Energy & Utilities, Financial Services, Logistics & Express, Pharmaceutical & Healthcare, Retail, Technology and Telecoms industries. Datamonitor's market intelligence products and services ensure that you will achieve your desired commercial goals by giving you the insight you need to best respond to your competitive environment. View more research from Datamonitor at http://www.fastmr.com/ About Fast Market Research Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. For more information about these or related research reports, please visit our website at http://www.fastmr.com or call us at 1.800.844.8156. # # # Fast Market Research is an online aggregator and distributor of market research and business information. We represent the world's top research publishers and analysts and provide quick and easy access to the best competitive intelligence available. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|